TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
728
Employees728
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
728
Employees728

TMDX Key Statistics

Market cap
4.80B
Market cap4.80B
Price-Earnings ratio
56.59
Price-Earnings ratio56.59
Dividend yield
Dividend yield
Average volume
905.02K
Average volume905.02K
High today
$140.99
High today$140.99
Low today
$137.00
Low today$137.00
Open price
$139.70
Open price$139.70
Volume
90.70K
Volume90.70K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$55.00
52 Week low$55.00

Stock Snapshot

TransMedics Group(TMDX) stock is priced at $140.43, giving the company a market capitalization of 4.8B. It carries a P/E multiple of 56.59.

On 2025-12-05, TransMedics Group(TMDX) stock traded between a low of $137.00 and a high of $140.99. Shares are currently priced at $140.43, which is +2.5% above the low and -0.4% below the high.

The TransMedics Group(TMDX)'s current trading volume is 90.7K, compared to an average daily volume of 905.02K.

During the past year, TransMedics Group(TMDX) stock moved between $55.00 at its lowest and $156.00 at its peak.

During the past year, TransMedics Group(TMDX) stock moved between $55.00 at its lowest and $156.00 at its peak.

TMDX News

Simply Wall St 4d
TransMedics: Evaluating Valuation After Strong Year-to-Date Share Price Gains

TransMedics Group (TMDX) has caught investor attention after trading higher by nearly 1% today. The company has seen substantial returns this year, which has sp...

TransMedics: Evaluating Valuation After Strong Year-to-Date Share Price Gains

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.